secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2022-07-20T23:59:59+00:00
Accession:  0001193125-22-197362
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health Q2 2022: Adj. EPS $8.04, revenue +15.6% to $38.5B; raises FY outlook
--------------------------------------------------------------------------------

- GAAP EPS $6.79; adjusted EPS $8.04, up 14.4% YoY.
- Operating revenue $38.5B, up 15.6% YoY; operating gain $2.4B, up 13.7%.
- Medical enrollment grew 2.7M members YoY to 47.1M; up 276K in quarter.
- Full-year adjusted EPS guidance raised to >$28.70, from prior >$28.25.
- Q3 dividend of $1.28/share declared; repurchased 1.3M shares for $624M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000119312522197362/0001193125-22-197362-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000119312522197362/d383286d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-197362

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer